Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Obesity

New weight loss drug helping people lose 2.5 stone is 'coming to the UK'

A weekly injection of tirzepatide has seen people with obesity and diabetes lose over 15 percent of their bodyweight.

Daily Record

Fat-fighting jab that helps you shed 100lbs in just a few months could be coming to UK

Since the drug was first approved last year, thousands of patients have obtained the drug from doctors and telehealth providers who prescribed it "off-label" to help them slim down

Daily Mirror

Young Latinas are seeing a staggering rise in uterine cancer — and experts don’t know why

Uterine cancer is generally more common in older women and is long known to disproportionately strike Black women. Now, new research adds to growing evidence that uterine cancer also is rising rapidly among reproductive-aged Hispanic women.

Chicago Sun-Times

From analysis to the latest developments in health,
read the most diverse news in one place.

What to know about prescription drugs promising weight loss

Obesity is a major and growing problem around the world, but especially in the U.S. Researchers have long looked for medications that can help people lose weight, mostly with disappointing and, in some cases, dangerous results

The Independent UK

Social Media adds to weight loss craze

GLP-1 agonists are a class of weight loss drug that is going viral on social media — but misinformation is rife

Salon

Eli Lilly releases more data for new obesity drug, moving toward fast-track approval

There's already a huge demand for existing weight-loss drugs, so the new medication is highly anticipated. Obesity affects an estimated 650 million adults globally.

WEKU

Powerful new obesity drug poised to upend weight loss care

A diabetes drug being tested for weight loss is poised to further upend obesity care

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Good Luck Paying for Those $10,000 Obesity Drugs Everyone’s Talking About

Ozempic, Wegovy and Mounjaro can cause dramatic weight loss, and could create a market worth $150 billion a year.

Businessweek

Why key to curing diabetes could be NHS-prescribed soups and shakes

‘Obesity is a significant factor and cause of several serious diseases’ warns NHS’ diabetes chief

The Independent UK

Diet culture can hurt kids. This author advises parents to reclaim the word 'fat'

Journalist Virginia Sole-Smith says efforts to fight childhood obesity have caused kids to absorb an onslaught of body-shaming messages. Her new book is Fat Talk.

WEKU

A ‘skinny jab’ is no quick fix for obesity – and no excuse to let junk food companies off the hook

Britain should be taxing unhealthy food and clamping down on marketing, says Sarah Boseley, the Guardian’s former health editor

The Guardian - UK

Novo Nordisk Sinks As Eli Lilly Plots Its Showdown In Obesity

Novo Nordisk stock dipped Monday after Eli Lilly posted the details of its study comparing Mounjaro and Wegovy in obesity treatment.

Investors Business Daily

Britain has an obesity crisis. We won’t solve it until we start listening to ‘nanny’

In failing to regulate the food sector, successive governments have allowed industry giants to flood the market with products that make us ill

The Guardian - UK

Larger-bodied airline passengers forced to pay for two seats prompts call for clearer anti-discrimination laws

Advocates say rules for ‘guests of size’ are inconsistent across Australian aviation, generating anxiety and unfair costs for those affected

The Guardian - AU

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

Social media is fueling enthusiasm for new weight loss drugs. Are regulators watching?

Suzette Zuena is her own best advertisement for weight loss.

Evening Standard

Losing weight on NHS soup and shake diet can ‘reverse’ type 2 diabetes

Obesity is a major cause of type 2 diabetes, and research suggests obese people are as much as 80 times more likely to develop the condition

The Guardian - UK

Nanny statism fears behind UK’s 30-year failure to tackle obesity, report says

IfG says Labour and Conservative governments have shied away from addressing subject seen as a minefield

The Guardian - UK

How UK governments from Major to Johnson tried to tackle obesity

Successive administrations have produced hundreds of policies to solve public health threat since 1990

Get all your
news in one place.

100’s of premium titles.
One news app.

Daily Mirror

UK 'faces higher taxes' as successive PMs have been 'too squeamish' to tackle obesity

The Institute for Government warned that a repeated failure to tackle the obesity epidemic will result in higher taxes and spending - with the problem already costing the NHS £6.5billion every year

The Independent UK

Losing weight can put type 2 diabetes in remission ‘for at least five years’

Obesity is a major driver of type 2 diabetes, with research suggesting that obese people are up to 80 times more likely to develop the condition.

The Independent UK

Government ‘squeamishness’ over tackling obesity ‘will lead to higher taxes’

The Institute for Government said rising UK obesity rates are harming people’s health, burdening the NHS and seriously damaging the economy.

WEKU

13 years after bariatric surgery, a 27-year-old says it changed her life

Maria Caprigno was one of the youngest people in the U.S. to get the surgery. As parents and doctors grapple with the obesity treatment for teens, Caprigno cites the long-term benefits.

Daily Record

'Super vegetable' helps you lose weight and decrease cancer risk, says new study

Eating the superfood can help aid your digestive system and decrease your risk of health issues such as inflammatory bowel disease, obesity and even cancer.

Tribune News Service

Diabetics’ weight loss drug Ozempic draws demand, and questions

Interest has exploded in a weight loss drug that was initially developed to help diabetics control their blood sugar.

Investors Business Daily

Novo Nordisk Surges To Another Record As Obesity Drugs Drive Higher Outlook

Novo Nordisk stock forged a new high Thursday after raising financial estimates, citing its diabetes and obesity treatments.

1 … 34 35 36 37

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the American Academy of Pediatrics

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.